Pages that link to "Q39719545"

The following pages link to Downregulation of EGFR by a novel multivalent nanobody-liposome platform. (Q39719545):

Displaying 36 items.

• Nanobodies as Versatile Tools to Understand, Diagnose, Visualize and Treat Cancer (Q26739702) (← links)
• The potential of polymeric micelles in the context of glioblastoma therapy (Q27693205) (← links)
• Where now for anti-EGF receptor therapies in colorectal cancer? (Q31038305) (← links)
• Small sized EGFR1 and HER2 specific bifunctional antibody for targeted cancer therapy (Q35086515) (← links)
• Green fluorescent protein nanopolygons as monodisperse supramolecular assemblies of functional proteins with defined valency (Q35631117) (← links)
• Molecular targeting of CEACAM6 using antibody probes of different sizes (Q36044493) (← links)
• Independent of ErbB1 gene copy number, EGF stimulates migration but is not associated with cell proliferation in non-small cell lung cancer (Q36847020) (← links)
• 3,4-dihydroxyphenyl acetic acid and (+)-epoxydon isolated from marine algae-derived microorganisms induce down regulation of epidermal growth factor activated mitogenic signaling cascade in Hela cells (Q36905911) (← links)
• Targeted alpha therapy using short-lived alpha-particles and the promise of nanobodies as targeting vehicle. (Q37085052) (← links)
• Interrogating tumor metabolism and tumor microenvironments using molecular positron emission tomography imaging. Theranostic approaches to improve therapeutics (Q37236103) (← links)
• Nanobody; an old concept and new vehicle for immunotargeting (Q37829737) (← links)
• Antiangiogenic anticancer strategy based on nanoparticulate systems. (Q37876400) (← links)
• Biotechnological applications of recombinant single-domain antibody fragments (Q37887077) (← links)
• Optimizing treatment of metastatic colorectal cancer patients with anti-EGFR antibodies: overcoming the mechanisms of cancer cell resistance. (Q38071119) (← links)
• Individualizing breast cancer treatment-The dawn of personalized medicine (Q38139723) (← links)
• Novel therapy based on camelid nanobodies (Q38151739) (← links)
• Nanobody-based cancer therapy of solid tumors (Q38322471) (← links)
• Site-specific conjugation of single domain antibodies to liposomes enhances photosensitizer uptake and photodynamic therapy efficacy. (Q38787937) (← links)
• Recent progress in protein-protein interaction study for EGFR-targeted therapeutics (Q38899428) (← links)
• Display of GPI-anchored anti-EGFR nanobodies on extracellular vesicles promotes tumour cell targeting (Q39027177) (← links)
• Efficient growth inhibition of EGFR over-expressing tumor cells by an anti-EGFR nanobody (Q39093873) (← links)
• 99mTc-Hydrazinonicotinamide Epidermal Growth Factor–Polyethylene Glycol–Quantum Dot Imaging Allows Quantification of Breast Cancer Epidermal Growth Factor Receptor Expression and Monitors Receptor Downregulation in Response to Cetuximab Therapy (Q39489058) (← links)
• Inhibition of HIV Virus by Neutralizing Vhh Attached to Dual Functional Liposomes Encapsulating Dapivirine (Q39575923) (← links)
• Human Antibody Fusion Proteins/Antibody Drug Conjugates in Breast and Ovarian Cancer (Q42660155) (← links)
• Nanobody-functionalized polymersomes for tumor-vessel targeting (Q44632061) (← links)
• Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeutics. (Q47099672) (← links)
• Nanobody-Based Delivery Systems for Diagnosis and Targeted Tumor Therapy (Q47121798) (← links)
• Quantum-Dot-Based Theranostic Micelles Conjugated with an Anti-EGFR Nanobody for Triple-Negative Breast Cancer Therapy. (Q47748669) (← links)
• Recombinant phosphatidylserine-binding nanobodies for targeting of extracellular vesicles to tumor cells: a plug-and-play approach. (Q48537610) (← links)
• Affinity enhancement of nanobody binding to EGFR: in silico site-directed mutagenesis and molecular dynamics simulation approaches. (Q52898287) (← links)
• Formulation, Development, and In Vitro Evaluation of a CD22 Targeted Liposomal System Containing a Non-Cardiotoxic Anthracycline for B Cell Malignancies. (Q55652135) (← links)
• Selective Cytotoxicity to HER2 Positive Breast Cancer Cells by Saporin-Loaded Nanobody-Targeted Polymeric Nanoparticles in Combination with Photochemical Internalization (Q64090598) (← links)
• EGFR-Targeted Nanobody Functionalized Polymeric Micelles Loaded with mTHPC for Selective Photodynamic Therapy (Q90108492) (← links)
• Lyophilized Iron Oxide Nanoparticles Encapsulated in Amphotericin B: A Novel Targeted Nano Drug Delivery System for the Treatment of Systemic Fungal Infections (Q90269060) (← links)
• Molecularly Engineered Nanobodies for Tunable Pharmacokinetics and Drug Delivery (Q90298981) (← links)
• Nanobodies: Next Generation of Cancer Diagnostics and Therapeutics (Q98466240) (← links)